SYNTHAVERSE S.A.

Highlights Synthaverse S.A.

Equities

SVE

PLBMDLB00018

Market Closed - Warsaw S.E. Other stock markets 16:55:55 01/07/2024 BST			5-day change	1st Jan Change
5.08 ^PLN	+0.40%		-0.97%	+18.97%

05-22	Synthaverse S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-10	Synthaverse S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Synthaverse S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-22	CI
Synthaverse S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	04-10	CI
Synthaverse S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-22	CI
Synthaverse S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	20/09/23	CI
BIOMED-LUBLIN WytwÃ³rnia Surowic i Szczepionek S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/05/23	CI
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	20/04/23	CI
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	07/11/22	CI
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	07/09/22	CI
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/05/22	CI
BIOMED-LUBLIN Wytw?rnia Surowic i Szczepionek S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	09/11/21	CI
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	31/08/21	CI
Biomed-Lublin Wytwórnia Surowic I Szczepionek S.A. Announces Earnings Results for the First Quarter of 2021	28/05/21	CI
Biomed-Lublin Wytwórnia Surowic I Szczepionek S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	02/03/21	CI
BIOMED LUBLIN Announces Earnings Results for the First Half Year 2020	15/09/20	CI
Polpharma SA Pharmaceutical Works signed an agreement to acquire Production Rights to Lakcid, Lakcid Forte & Lakcid L Brands from BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek Spólka Akcyjna for PLN 17 million.	31/10/17	CI
Organizacja Polskich Dystrybutorow Farmaceutycznych S A acquired an additional 10.79% stake in BIOMED-LUBLIN Wytwornia Surowic i Szczepionek Spolka Akcyjna from Intra Stanislaw Bogdansk.	02/11/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer